Josh Bartch, Mydecine Innovations Group

from Psychedelic Spotlight Podcast · host Mydecine Innovations Group, Psychedelic Spotlight, Global Trac Solutions Inc., PSYC, David Flores, Josh Bartch

To learn more about Mydecine Innovations Group and the work they're doing be sure to visit their website, Mydecine.com. Investors can find them on the Canadian Securities Exchange under the symbol MYCO, or on the OTC Markets under the symbol MYCOF.Get the latest industry news around all things psychedelics by visiting our website, PsychedelicSpotlight.com, and be sure to subscribe to our newsletter to never miss a thing.

Episode metadata supplied by the publisher feed · Published Jan 27, 2021

Embed this episode

Attribution link and audio player

What this episode covers

Global Trac Solutions, Inc. CEO, David Flores sits down to speak with Co-Founder & CEO, of Mydecine Innovations Group, Josh Bartch. David and Josh take some time to talk about Mydecine as a company, and, what path they're taking in 2021, the passing of Measure 109 in Oregon, aiding veterans through psychedelics, and more.

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Josh Bartch, Mydecine Innovations Group

0:00 17:07

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Psychedelic Spotlight Podcast?

This episode is 17 minutes long.

When was this Psychedelic Spotlight Podcast episode published?

This episode was published on January 27, 2021.

Can I download this Psychedelic Spotlight Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!